Ambica Pharma Machines Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-10-2024
- Paid Up Capital ₹ 85.00 K
as on 23-10-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.60 Cr
as on 23-10-2024
- Revenue 38.74%
(FY 2023)
- Profit 90.86%
(FY 2023)
- Ebitda 86.13%
(FY 2023)
- Net Worth 11.64%
(FY 2023)
- Total Assets 3.62%
(FY 2023)
About Ambica Pharma Machines
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 85.00 K .
The company currently has active open charges totaling ₹2.60 Cr.
Ashok Mistry and Manaswi Mistry serve as directors at the Company.
- CIN/LLPIN
U24297GJ2006PTC048387
- Company No.
048387
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jun 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ambica Pharma Machines Private Limited offer?
Ambica Pharma Machines Private Limited offers a wide range of products and services, including Marking and Stamping Machines, Labelling Machines, Pharmaceutical Machinery & Equipment, Pharmaceutical Machines, Paper Work & Making Machine, Cup Making Machine, Filling Machines & Plants, Powder Filling Machine, Audio Mixer, Recorder & Transmitter, DJ Equipment.
Who are the key members and board of directors at Ambica Pharma Machines?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Mistry  | Director | 04-Jun-2006 | Current |
| Manaswi Mistry | Director | 04-Jun-2006 | Current |
Financial Performance of Ambica Pharma Machines.
Ambica Pharma Machines Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 38.74% increase. The company also saw a substantial improvement in profitability, with a 90.86% increase in profit. The company's net worth Soared by an impressive increase of 11.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ambica Pharma Machines?
In 2023, Ambica Pharma Machines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 12 Mar 2013 | ₹2.60 Cr | Open |
How Many Employees Work at Ambica Pharma Machines?
Ambica Pharma Machines has a workforce of 37 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ambica Pharma Machines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ambica Pharma Machines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
